LionBird

Venture Capital Active Tel Aviv-Yafo, Israel Est. 2012
Last updated 2026-06-18
Portfolio
27
in our dataset
Rounds participated
41
Rounds led
5
Rounds' value
$420.5M
total disclosed, rounds participated
Stages
A Round, B Round, Pre-Seed, Seed

About

LionBird is a venture capital firm investing in pre-scale digital health companies with operations in Tel Aviv and the U.S. LionBird provides capital and assistance to mission-driven teams realigning the human-technology relationship in healthcare. Since its inception, the firm has invested in more than 30 founding teams across the U.S. and Israel. The firm is currently investing out of its third fund, LionBird III, exclusively focused on early-stage digital health.

Portfolio · 27

Jimini Health
Responsible AI-Supported Therapy
2 rounds $25.0M committed Latest: 2026-03
PhaseV
ML for Clinical Trial Optimization
2 rounds $65.0M committed Latest: 2025-05
Rhino Federated Computing
Federated Computing Platform for Secure Decentralized Data Collaboration
Led ★ 3 rounds $26.7M committed Latest: 2025-05
OneStep
Inspiring Health Through Motion
2 rounds $45.0M committed Latest: 2024-10
Ruby Health
Value-based Care at Home
1 round Latest: 2024-09
Ecton
AI-Driven Healthcare Payment Solutions
1 round Latest: 2024-01
Mana.bio
AI-based Programmable Drug Delivery
2 rounds $19.5M committed Latest: 2023-10
Chiefy
Clinical Communication and Collaboration System
Led ★ 1 round $4.2M committed Latest: 2023-04
Nest Health
Genomics Software Solutions for Health Systems
1 round $8.5M committed Latest: 2023-01
Black Ore
Transformative AI for Financial Services
1 round $60.0M committed Latest: 2022-11
FundGuard
Cloud-Native, AI-powered Investment Accounting Platform
3 rounds $56.0M committed Latest: 2022-04
Mellie
Care Management Platform
1 round Latest: 2022-03
Maverick Medical AI
AI-based Autodidactic and Autonomous Medical Coding Platform
Led ★ 1 round $8.0M committed Latest: 2022-03
Laguna Health
Conversational Care Intelligence
1 round $6.6M committed Latest: 2021-05
Nimble Beauty
Nail-painting Robot
2 rounds $10.2M committed Latest: 2021-05
Assured Allies
Longevity Risk Management Platform
Led ★ 2 rounds $22.5M committed Latest: 2020-12
BrainVivo
Unlocking Human Brain Intelligence
1 round Latest: 2019-10
C2i Genomics
Whole-genome Cancer Treatment Intelligence Platform
1 round $1.2M committed Latest: 2019-08
TytoCare
Remote Primary Care and a Home Smart Clinic
2 rounds $32.0M committed Latest: 2018-01
Bizzabo
Platform for Event Planning and Management
1 round $6.5M committed Latest: 2017-04
LawGeex
AI-powered Contract Review Automation
2 rounds $9.5M committed Latest: 2017-03
Telesofia Medical
Educational Videos for Medical Information
Led ★ 1 round Latest: 2016-12
Sweetch
AI-Powered Hyper-Personalized Patient Engagement Platform
2 rounds $4.8M committed Latest: 2016-04
Genome Compiler
Personalized Synthetic Genome Design
1 round $5.8M committed Latest: 2015-06
CartCrunch
A Grocery Cost Comparison App
2 rounds $2.2M committed Latest: 2014-02
PhysiMax Technologies
AI-powered Musculoskeletal Self-assessment and Optimization Platform
1 round Latest: 2013-04
streamOnce
Team Collaboration Software
1 round $1.4M committed Latest: 2012-07

Investment activity

5 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences20
Business Software5
Fintech & Insurtech3

Funds · 3

  • 3 — $85M Apr 2022
  • 2 — $35M Jul 2017
  • 1 — $20M Oct 2013

Q&A

What is LionBird's primary investment focus?
LionBird is a venture capital firm that exclusively invests in early-stage digital health companies, with operations in Tel Aviv and the U.S.
When did LionBird close its most recent fund, and what was its size?
LionBird closed its third fund, Fund 3, in April 2022, raising $85 million. This fund is exclusively focused on early-stage digital health.
Can you name a recent notable exit for LionBird?
In January 2024, LionBird saw an exit with the acquisition of C2i Genomics by Veracyte for $95 million. C2i Genomics is a whole-genome cancer treatment intelligence platform.
Which sectors does LionBird primarily invest in?
LionBird's portfolio shows a strong concentration in Health Tech & Life Sciences, accounting for 20 of its portfolio companies. They also have investments in Business Software and Fintech & Insurtech.
Who are the managing partners at LionBird?
The managing partners at LionBird are Chaim Friedman and Edward Michael, both of whom are also founders of the firm.
What are some of LionBird's recent investments in the digital health space?
LionBird has recently invested in companies like Chiefy, a clinical communication and collaboration system, and Jimini Health, which focuses on AI-supported therapy, both founded in 2023.
What investment stages does LionBird typically target?
LionBird primarily targets Pre-Seed, Seed, A Round, and B Round investments. Their most frequent investments are at the Seed stage.
Has LionBird had any other significant exits in the past two years?
Yes, in January 2022, LionBird had an exit with the acquisition of PhysiMax Technologies by DarioHealth for $6 million. PhysiMax Technologies offers an AI-powered musculoskeletal self-assessment platform.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)